Dagna Laufer

1.9k total citations
15 papers, 530 citations indexed

About

Dagna Laufer is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Dagna Laufer has authored 15 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 6 papers in Infectious Diseases and 4 papers in Virology. Recurrent topics in Dagna Laufer's work include HIV Research and Treatment (4 papers), Respiratory viral infections research (3 papers) and HIV/AIDS Research and Interventions (3 papers). Dagna Laufer is often cited by papers focused on HIV Research and Treatment (4 papers), Respiratory viral infections research (3 papers) and HIV/AIDS Research and Interventions (3 papers). Dagna Laufer collaborates with scholars based in United States, United Kingdom and Kenya. Dagna Laufer's co-authors include Frank Malinoski, Steven Black, John Hansen, Henry R. Shinefield, Barbara Watson, Stuart E. Starr, Galit Alter, Nancy B. Tustin, Chris Boardman and Patricia Fast and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Annals of the New York Academy of Sciences.

In The Last Decade

Dagna Laufer

14 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dagna Laufer United States	11	388	155	95	80	74	15	530
Jisheng Lin United States	12	363 0.9×	206 1.3×	57 0.6×	128 1.6×	53 0.7×	22	552
Stéphane Thomas France	13	442 1.1×	128 0.8×	80 0.8×	99 1.2×	24 0.3×	35	547
John Treanor United States	8	790 2.0×	54 0.3×	290 3.1×	264 3.3×	120 1.6×	8	1.0k
Nahmias Aj United States	11	587 1.5×	81 0.5×	70 0.7×	163 2.0×	28 0.4×	19	721
Ashwani Kumar Arora Italy	14	403 1.0×	140 0.9×	129 1.4×	126 1.6×	66 0.9×	39	553
Edith C. Sannella United States	10	470 1.2×	34 0.2×	171 1.8×	215 2.7×	57 0.8×	13	603
Staffan Sylvan Sweden	16	410 1.1×	82 0.5×	114 1.2×	174 2.2×	48 0.6×	55	603
Karen E. Mark United States	13	577 1.5×	74 0.5×	190 2.0×	178 2.2×	32 0.4×	21	798
Volker Vetter Belgium	12	204 0.5×	108 0.7×	91 1.0×	195 2.4×	80 1.1×	24	523
N. A. Halsey United States	11	375 1.0×	49 0.3×	77 0.8×	183 2.3×	51 0.7×	13	517

Countries citing papers authored by Dagna Laufer

Since Specialization

Citations

This map shows the geographic impact of Dagna Laufer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dagna Laufer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dagna Laufer more than expected).

Fields of papers citing papers by Dagna Laufer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dagna Laufer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dagna Laufer. The network helps show where Dagna Laufer may publish in the future.

Co-authorship network of co-authors of Dagna Laufer

This figure shows the co-authorship network connecting the top 25 collaborators of Dagna Laufer. A scholar is included among the top collaborators of Dagna Laufer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dagna Laufer. Dagna Laufer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Parker, Rachel, Julien Nyombayire, Matt A. Price, et al.. (2019). Female sex workers in Kigali, Rwanda: a key population at risk of HIV, sexually transmitted infections, and unplanned pregnancy. International Journal of STD & AIDS. 30(6). 557–568. 24 indexed citations

Mahan, Alison E., Madeleine F. Jennewein, Todd J. Suscovich, et al.. (2016). Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination. PLoS Pathogens. 12(3). e1005456–e1005456. 107 indexed citations

Mutua, Gaudensia, Juliet Mpendo, William Kilembe, et al.. (2014). Major Negative Social Impacts Are Rare in Phase 1 HIV Vaccine Trials in Africa. AIDS Research and Human Retroviruses. 30(S1). A190–A191. 2 indexed citations

Omosa-Manyonyi, Gloria, Gaudensia Mutua, Bashir Farah, et al.. (2014). Acceptability and Feasibility of Repeated Mucosal Specimen Collection in Clinical Trial Participants in Kenya. PLoS ONE. 9(10). e110228–e110228. 4 indexed citations

Nyombayire, Julien, Etienne Karita, Dagna Laufer, et al.. (2014). Acceptability of Multiple Mucosal Specimen Collection in a Phase 1 HIV Vaccine Trial in Rwanda. AIDS Research and Human Retroviruses. 30(S1). A236–A236.

Hayes, Peter, Jill Gilmour, Dilbinder K. Gill, et al.. (2013). Safety and Immunogenicity of DNA Prime and Modified Vaccinia Ankara Virus-HIV Subtype C Vaccine Boost in Healthy Adults. Clinical and Vaccine Immunology. 20(3). 397–408. 22 indexed citations

Fletcher, M A, Dagna Laufer, E. David G. McIntosh, C Cimino, & Frank Malinoski. (2006). Controlling invasive pneumococcal disease: is vaccination of at-risk groups sufficient?. International Journal of Clinical Practice. 60(4). 450–456. 19 indexed citations

Black, Steven, C Cimino, John Hansen, et al.. (2006). Immunogenicity and Safety of Measles-Mumps-Rubella, Varicella and Haemophilus influenzae Type b Vaccines Administered Concurrently With a Fourth Dose of Heptavalent Pneumococcal Conjugate Vaccine Compared With the Vaccines Administered Without Heptavalent Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal. 25(4). 306–311. 16 indexed citations

Black, Steven, et al.. (2001). Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. The Pediatric Infectious Disease Journal. 20(12). 1105–1107. 194 indexed citations

10.

Watson, Barbara, Dagna Laufer, Barbara J. Kuter, BRENDA O. STAEHLE, & C. J. White. (1996). Safety and Immunogenicity of a Combined Live Attenuated Measles, Mumps, Rubella, and Varicella Vaccine (MMRIIV) in Healthy Children. The Journal of Infectious Diseases. 173(3). 731–734. 35 indexed citations

11.

Watson, Barbara, Jill A. Foster, C. J. White, & Dagna Laufer. (1996). Varicella in the normal and immunocompromised host. 3(3). 425–438. 3 indexed citations

12.

Laufer, Dagna, William M. Hurni, Barbara Watson, et al.. (1995). Saliva and Serum as Diagnostic Media for Antibody to Hepatitis A Virus in Adults and in Individuals Who Have Received an Inactivated Hepatitis A Vaccine. Clinical Infectious Diseases. 20(4). 868–871. 16 indexed citations

13.

Watson, Barbara, Chris Boardman, Dagna Laufer, et al.. (1995). Humoral and Cell-Mediated Immune Responses in Healthy Children After One or Two Doses of Varicella Vaccine. Clinical Infectious Diseases. 20(2). 316–319. 61 indexed citations

14.

Laufer, Dagna & Stuart E. Starr. (1995). Resistance to Antivirals. Pediatric Clinics of North America. 42(3). 583–599. 17 indexed citations

15.

Hurni, William M., et al.. (1993). Anti‐Hepatitis A in the General Population and in Hepatitis A Vaccinees Using Saliva and Serum as Diagnostic Media. Annals of the New York Academy of Sciences. 694(1). 289–292. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact